Varicella vaccine in children
DOI:
https://doi.org/10.32385/rpmgf.v28i2.10928Keywords:
Chickenpox vaccine, Infant, Child, PreschoolAbstract
VARICELLA VACCINE IN CHILDREN Objectives: To review the available evidence for varicella vaccination in healthy children, analyzing its effectiveness and safe- ty. Data sources: MEDLINE database and evidence-based medicine websites. Methods: A search was conducted for guidelines, systematic reviews, meta-analyses and original studies, published between January 2005 and November 2009, in English, Portuguese and Spanish, using the MeSH terms chickenpox vaccine, infant, child preschool and child. The SORT (Strength of Recommendation Taxonomy) scale of the American Family Physician was applied to evaluate the level of evidence. Results: We found 14 studies that assessed vaccine effectiveness: 5 guidelines (2 with strength of recommendation A) 3 sys- tematic reviews (2 with evidence level 1), one meta-analysis (evidence level 1), a case-control study and 4 cohort studies. Stud- ies showed that the vaccine has an effectiveness of 70 to 90% in preventing all forms of varicella and 95 to 100% in prevent- ing moderate to severe disease, over a period not exceeding ten years. The two-dose regimen showed greater long-term effec- tiveness than the single dose regimen. Two studies evaluating vaccine safety concluded that the vaccine is safe and well toler- ated (one randomized controlled trial with evidence level 1). Conclusion: Varicella vaccine is effective and safe in healthy children (Strength of Recommendation A). However, its imple- mentation should be universal, to allow a high coverage rate, considering the possibility of a two-dose regimen.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
